Restoring autophagic flux by treating TLR2-deficient mice with IFN-γ, a T-helper 1 (Th1) cytokine and positive modulator of autophagy, attenuated the carcinogenesis and progression of HCC in TLR2-deficient mice (68). This evidence concerns the gene TLR2 and hepatocellular carcinoma.